CERNOSTICS, INC.
FRIENDSWOOD, TX

Cernostics, Inc., established on August 29, 2016, is a diagnostics company headquartered in Friendswood, Texas. The firm specializes in next-generation cancer diagnostics and prognostics by employing a pioneering approach to tissue analysis through its proprietary TissueCypher™ platform. Cernostics is distinguished for its commitment to enhancing healthcare outcomes via genomic and proteomic technologies. Led by CEO Mike Hoerres, who brings over 30 years of expertise in the life sciences industry and strategic market building experience from his previous role as a Principal at Geisinger Ventures, the company excels in innovation and personalizing healthcare solutions. Under his leadership, Cernostics strategically collaborates with partners such as Geisinger Health System to drive advancements in diagnostic development and personalized medicine. The R&D team is spearheaded by Dr. Critchley-Thorne, an expert in cancer immunology who focuses on molecular and functional profiling of patient samples and has previously collaborated with the Mayo Clinic on breast cancer diagnostics research. Additionally, seasoned professionals like Noel Doheny contribute their extensive experience from distinguished roles across various global diagnostic markets to bolster Cernostics' strategic initiatives. Cernostics' leadership team also includes notable names such as Courtland Longest, a marketing and product management expert who currently directs precision medicine projects at UPMC Enterprises and serves on the board of directors for Cernostics. Collectively, their diverse expertise fuels innovation in developing cutting-edge diagnostic solutions that cater to unmet needs within oncology. Registered as an active Florida corporation with its last annual report filed in January 2025, Cernostics continues expanding its influence and impact in transforming cancer care through precision diagnostics. The company's comprehensive approach extends services via its operational base in Friendswood, Texas, reachable by phone at (412) 820-3050 or online through their official website.